e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Idiopathic pulmonary fibrosis: time for greater expectations?
Wim Wuyts, Vincent Cottin
Source:
Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018
Journal Issue:
August
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wim Wuyts, Vincent Cottin. Idiopathic pulmonary fibrosis: time for greater expectations?. Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021
Year: 2022
Severe idiopathic pulmonary fibrosis: what can be done?
Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017
Year: 2017
Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Idiopathic pulmonary fibrosis (IPF): the patient journey
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020
The lived experience of idiopatic pulmonary fibrosis: A qualitative study
Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Year: 2016
The therapy of idiopathic pulmonary fibrosis: what is next?
Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019
Year: 2019
A global registry for idiopathic pulmonary fibrosis: the time is now
Source: Eur Respir J 2014; 44: 273-276
Year: 2014
Idiopathic pulmonary fibrosis: a treatable disease?
Source: Eur Respir J 2003 Dec 01;22(6):872-873
Year: 2003
Idiopathic pulmonary fibrosis: securing a confident diagnosis for every patient
Source: Eur Respir J 2016; 47: 1057-1059
Year: 2016
Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation
Source: Eur Respir J 2012; 40: 794-795
Year: 2012
Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease
Source: Eur Respir J 2016; 48: 26-28
Year: 2016
Idiopathic pulmonary fibrosis: Relationship between patient survival and distance-saturation product
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging
Source: Eur Respir J 2015; 46: 604-606
Year: 2015
Exercise training in idiopathic pulmonary fibrosis: is it of benefit?
Source: Breathe 2016; 12: 130-138
Year: 2016
Idiopathic pulmonary fibrosis: present understanding and future options
Source: Eur Respir Rev 2011; 20: 132-133
Year: 2011
Idiopathic pulmonary fibrosis: does smoking status influence outcome?
Source: Eur Respir J 2006; 28: Suppl. 50, 830s
Year: 2006
Home spirometry for idiopathic pulmonary fibrosis: ready for prime time?
Source: Eur Respir J, 50 (1) 1701403; 10.1183/13993003.01403-2017
Year: 2017
Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Idiopathic pulmonary fibrosis: approaches to diagnostic
Source: Eur Respir J 2002; 20: Suppl. 38, 61s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept